The newest addition to Cetero Research, dgd Research, is a contract research organization with 24 years of experience conducting clinical research. They have performed more than 1,500 Phase I-IV clinical trials in diabetes, hypertension, neuropathy, osteoporosis, hypercholesterolemia, obesity, menopause, and nephropathy.

DGD Research specializes in endocrine disorders with diabetes as their primary focus. Development of new diabetic therapies is the second largest drug development area - second only to cancer.